Peters Thomas Phineas 13D and 13G filings for Nuvectis Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-30 9:01 pm Sale | 2023-12-31 | 13G | Nuvectis Pharma, Inc. NVCT | Peters Thomas Phineas | 908,475 5.200% | -39,183 (-4.13%) | Filing |
| 2023-04-03 08:15 am Purchase | 2022-02-04 | 13G | Nuvectis Pharma, Inc. NVCT | Peters Thomas Phineas | 947,658 6.400% | 947,658 (New Position) | Filing |